Therapeutic Advances in Respiratory Disease

Scope & Guideline

Empowering Progress in Respiratory Disease Management

Introduction

Welcome to the Therapeutic Advances in Respiratory Disease information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Therapeutic Advances in Respiratory Disease, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1753-4658
PublisherSAGE PUBLICATIONS LTD
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Convergefrom 2007 to 2024
AbbreviationTHER ADV RESPIR DIS / Ther. Adv. Respir. Dis.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND

Aims and Scopes

The journal 'Therapeutic Advances in Respiratory Disease' primarily focuses on advancing knowledge and therapeutic strategies related to respiratory diseases. It encompasses a broad range of studies aimed at improving patient outcomes through innovative research and clinical practice. The journal emphasizes the integration of clinical findings, therapeutic advancements, and patient-reported outcomes in the field of respiratory health.
  1. Clinical Research in Respiratory Diseases:
    The journal publishes original research on various respiratory diseases, including asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, and infections, emphasizing clinical trials and observational studies.
  2. Innovative Therapeutic Approaches:
    It highlights studies on novel therapeutic interventions, including pharmacological treatments, biologics, and advanced medical technologies such as robotic-assisted bronchoscopy and endobronchial ultrasound.
  3. Diagnostic Advances:
    Research focusing on novel diagnostic methods and biomarkers for respiratory diseases is a key area, including studies on imaging techniques, molecular diagnostics, and the validation of clinical assessment tools.
  4. Patient-Centered Outcomes:
    The journal places a strong emphasis on patient-reported outcomes, quality of life assessments, and the psychosocial aspects of living with respiratory diseases, aiming to incorporate patient perspectives into clinical practice.
  5. Epidemiology and Public Health:
    It includes epidemiological studies that analyze the prevalence, risk factors, and burden of respiratory diseases in various populations, providing insights into public health implications.
Recent publications in 'Therapeutic Advances in Respiratory Disease' reflect emerging trends and themes that are gaining traction. These areas indicate the journal's responsiveness to current challenges and advancements in respiratory medicine.
  1. Personalized Medicine and Biomarkers:
    There is a growing focus on personalized treatment strategies and the identification of biomarkers that guide therapy, particularly in complex diseases like asthma and COPD, highlighting the importance of individualized patient care.
  2. Impact of COVID-19 on Respiratory Health:
    Research examining the long-term effects of COVID-19 on respiratory health, including post-acute sequelae and rehabilitation strategies, has seen a significant rise, reflecting an urgent need for addressing the pandemic's implications.
  3. Interventional Pulmonology Techniques:
    Emerging interest in advanced interventional techniques such as endobronchial ultrasound and robotic bronchoscopy is evident, showcasing the journal's commitment to reporting on innovative procedures that enhance diagnostic and therapeutic capabilities.
  4. Telemedicine and Digital Health Solutions:
    The incorporation of telemedicine and digital health solutions into respiratory disease management is trending, with studies focusing on their effectiveness in improving access to care and patient outcomes during and after the COVID-19 pandemic.
  5. Multidisciplinary Approaches to Treatment:
    There is an increasing emphasis on multidisciplinary care models that integrate various specialties to address the complex needs of patients with respiratory diseases, reflecting a holistic approach to treatment.

Declining or Waning

As the field evolves, certain themes within 'Therapeutic Advances in Respiratory Disease' appear to be losing prominence. This decline may reflect shifting research priorities or advancements in understanding that have made some previously emphasized topics less critical or relevant.
  1. Traditional Therapeutic Approaches:
    There is a noticeable decrease in research focusing solely on traditional pharmacological therapies, such as older inhalers and medications, as more emphasis is placed on novel therapies and personalized medicine.
  2. Basic Science Research:
    The journal has seen a reduction in the publication of purely basic science studies that do not directly translate to clinical application, indicating a shift towards more clinically relevant research.
  3. Single-Disease Focus Studies:
    Research dedicated to single diseases without interdisciplinary approaches is waning, as the journal increasingly emphasizes studies that consider comorbid conditions and multifactorial influences on respiratory health.

Similar Journals

Pulmonology

Elevating knowledge and practice in pulmonary medicine.
Publisher: ELSEVIERISSN: 2531-0437Frequency: 6 issues/year

Pulmonology, an esteemed journal published by Elsevier, serves as a vital platform for advancing knowledge in the field of Pulmonary and Respiratory Medicine. Since its transition to Open Access in 2018, this journal has successfully fostered a global readership, allowing for unrestricted dissemination of cutting-edge research. With an impressive Scopus ranking of #8 out of 155 in its category and a notable 2023 Q1 status, Pulmonology consistently showcases high-quality studies and reviews that contribute to the understanding and treatment of respiratory disorders. Authors and readers alike benefit from its commitment to publish influential research that addresses contemporary challenges in lung health. By bridging the gap between theory and clinical practice, the journal paves the way for innovative practices in pulmonology, making it an indispensable resource for researchers, healthcare professionals, and students interested in this dynamic field.

Advances in Respiratory Medicine

Driving impactful research for respiratory wellness.
Publisher: MDPIISSN: 2451-4934Frequency: 6 issues/year

Advances in Respiratory Medicine is a distinguished open-access journal published by MDPI, focusing on the latest research and developments in the field of pulmonary and respiratory medicine. Launched in 2015 and operating out of Switzerland, this journal aims to advance scientific discourse and knowledge by providing a platform for researchers, clinicians, and health professionals. With an impressive ISSN of 2451-4934 and an E-ISSN of 2543-6031, it has made its mark in the academic community, reflected by its impact factor and recognition in the Q3 category for Pulmonary and Respiratory Medicine as of 2023. The journal enjoys a ranking of #95 out of 155 in Scopus within its category, providing authors with visibility and the potential for impactful dissemination of their research. Open access since 2022, it ensures that findings are readily available to all, fostering collaboration and innovation across disciplines. With a commitment to quality and rigor, Advances in Respiratory Medicine invites contributions that push the boundaries of existing knowledge, making it an invaluable resource for anyone dedicated to enhancing respiratory health.

Expert Review of Respiratory Medicine

Advancing Respiratory Health Through Expert Insights
Publisher: TAYLOR & FRANCIS LTDISSN: 1747-6348Frequency: 6 issues/year

Expert Review of Respiratory Medicine is a leading journal published by Taylor & Francis Ltd, dedicated to advancing the field of respiratory medicine through evidence-based research and comprehensive reviews. With a robust ISSN of 1747-6348 and an E-ISSN of 1747-6356, the journal disseminates essential insights into pulmonary and respiratory health, ranking an impressive #33 in Medicine - Pulmonary and Respiratory Medicine on Scopus, reflecting its significant contribution to this discipline. Established in 2007 and extending its reach through 2024, Expert Review of Respiratory Medicine serves as a crucial resource for professionals and researchers dedicated to improving respiratory health outcomes. Though not designated as an open-access journal, its impactful articles are pivotal in shaping clinical practices and guiding future research in respiratory medicine and related fields, including public health and immunology. By engaging with this journal, readers can stay abreast of the latest developments and critically evaluate advancements in respiratory care.

Turkish Thoracic Journal

Empowering knowledge for better respiratory health solutions.
Publisher: AVESISSN: Frequency: 6 issues/year

Turkish Thoracic Journal, published by AVES, is a prominent open-access platform dedicated to advancing the field of pulmonary and respiratory medicine. Since its establishment, the journal has aimed to disseminate significant research findings, clinical studies, and reviews that contribute to an improved understanding of respiratory health challenges, with a particular focus on the Turkish context and regional issues. With an E-ISSN of 2149-2530 and transitioning to open access in 2022, the journal enhances visibility and accessibility, inviting a global audience of researchers, clinicians, and students to engage with the latest scientific work. The Turkish Thoracic Journal has been indexed in major databases, although it faced a coverage discontinuation in Scopus between 2016 and 2022. Currently positioned within the 23rd percentile among its peers in the field, it invites submissions that explore innovative approaches to thoracic health, enriching the discourse in a vital area of medicine.

Jornal Brasileiro de Pneumologia

Fostering collaboration in the pursuit of better lung health.
Publisher: SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIAISSN: 1806-3713Frequency: 6 issues/year

Jornal Brasileiro de Pneumologia is a pivotal open-access journal in the field of Pulmonary and Respiratory Medicine, published by SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIA. Established in 2004, this esteemed publication has become a significant platform for researchers, health professionals, and students in Brazil and beyond, facilitating the exchange of innovative ideas and vital research findings. The journal is indexed in Scopus and is recognized in the 2023 category quartiles as Q3, ranking 86 out of 155 in its field with a corresponding 44th percentile. This reflects its growing influence and commitment to advancing knowledge concerning respiratory health. With a mission to disseminate high-quality research, the journal aims to foster advancements in clinical practice and improve outcomes in pulmonary diseases, making it an essential resource for those dedicated to enhancing the quality of care in respiratory medicine. For those seeking comprehensive access to critical studies and reviews in this domain, the Jornal Brasileiro de Pneumologia remains an invaluable asset.

Multidisciplinary Respiratory Medicine

Advancing respiratory health through collaborative research.
Publisher: MATTIOLI 1885ISSN: 1828-695XFrequency: 1 issue/year

Multidisciplinary Respiratory Medicine is a leading open-access journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by MATTIOLI 1885, this journal has been serving the academic community since 2008 and has become a vital platform for the dissemination of research and clinical insights in this critical area of healthcare. With an impressive impact factor placing it in the Q2 category of pulmonary medicine in 2023 and a Scopus rank of #67 out of 155, it reflects a solid commitment to high-quality research. The journal provides researchers, health professionals, and students with accessible and updated information, fostering collaboration and advancement in respiratory health. Operating from the United Kingdom, it has embraced open access since 2010, ensuring that all articles are freely available, thus maximizing the reach and impact of its scholarly contributions. Whether you are looking to publish innovative findings or gain insights from industry leaders, Multidisciplinary Respiratory Medicine is your go-to resource for the latest in respiratory science.

LUNG

Innovating the future of pulmonary medicine with every publication.
Publisher: SPRINGERISSN: 0341-2040Frequency: 6 issues/year

LUNG is a prestigious academic journal that has been a cornerstone in the field of Pulmonary and Respiratory Medicine since its inception in 1959. Published by SPRINGER, the journal holds an impressive Q1 ranking in its category for 2023, reflecting its commitment to disseminating high-quality research and advancing clinical practices in respiratory health. With a Scopus rank of 24 out of 155 in its field, representing the top 16% of journals, LUNG continues to serve as a vital platform for researchers, clinicians, and students who are dedicated to addressing the complexities of lung diseases. Although currently not an open-access journal, LUNG offers valuable insights and significant contributions to the understanding of respiratory conditions, ensuring that its readership stays at the forefront of medical advancements. Researchers and professionals are encouraged to submit their work and engage with a thriving academic community that is passionate about improving patient outcomes in pulmonary health.

Lancet Respiratory Medicine

Pioneering discoveries in pulmonary medicine.
Publisher: ELSEVIER SCI LTDISSN: 2213-2600Frequency: 12 issues/year

The Lancet Respiratory Medicine, published by Elsevier in the United Kingdom, is a premier journal dedicated to the field of pulmonary and respiratory medicine. With its impressive impact factor and a prestigious ranking of #1 out of 155 in its category as of 2023, it holds a remarkable position in advancing research and clinical practices in respiratory health. The journal invites original research, reviews, and clinical studies that aim to propel the understanding of respiratory diseases, fostering innovations in treatment and management strategies. Operating under a Q1 category in Scopus rankings, it is an essential platform for researchers, healthcare professionals, and students who are committed to enhancing patient care and advancing knowledge in this crucial area of medicine. The Lancet Respiratory Medicine remains a vital resource for the latest findings and discussions shaping the future of respiratory health.

RESPIRATORY RESEARCH

Unlocking Innovations in Respiratory Medicine
Publisher: BMCISSN: Frequency: 1 issue/year

RESPIRATORY RESEARCH is a leading open-access journal published by BMC, dedicated to advancing the field of pulmonary and respiratory medicine. Since its inception in 2000, this journal has provided a vital platform for disseminating high-quality research, covering a broad spectrum of topics from basic science to innovative clinical practices in respiratory health. With an impressive impact factor and a Q1 ranking in the Pulmonary and Respiratory Medicine category, RESPIRATORY RESEARCH is recognized for its significant contribution to the literature, currently positioned at rank #19 out of 155 in the Scopus database, highlighting its relevance and influence within the medical community. The journal’s commitment to open access ensures that all articles are freely available to researchers, professionals, and students, fostering collaboration and knowledge sharing in the field. With its convergence years spanning from 2000 to 2024, RESPIRATORY RESEARCH remains at the forefront of respiratory medicine research, making it an essential resource for all stakeholders in this vital medical domain.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Transforming critical care practices with peer-reviewed excellence.
Publisher: AMER THORACIC SOCISSN: 1073-449XFrequency: 24 issues/year

American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society, is a leading scholarly journal dedicated to advancing the fields of critical care and pulmonary medicine. With an impressive impact factor and recognized in the Q1 quartile for both Critical Care and Pulmonary Medicine, this journal is essential reading for researchers, clinicians, and students invested in innovative practices and therapies in respiratory health. Through high-quality, peer-reviewed research articles, the journal addresses significant contemporary issues in respiratory and critical care, offering unparalleled insights and fostering interdisciplinary collaboration. Although the journal adheres to a traditional subscription model, it remains a cornerstone for those wishing to stay at the forefront of medical science in this vital area. With its extensive historical context since its establishment in 1991 and continuous publication spanning through 2024, the journal is committed to promoting discourse and disseminating knowledge that ultimately enhances patient care and clinical outcomes.